Low vitamin D levels affect drug efficacy in HCV patients

12/20/2009 | Medscape (free registration)

An Italian study showed hepatitis C patients have lower serum levels of 25-hydroxyvitamin D than people without the virus, which affects treatment efficacy. The study showed that as vitamin D levels decline, so do the chances that a patient with chronic HCV will have a sustained response to interferon and ribavirin.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN